IonMedicine

IonMedicine has used as its primary work instrument metabolomics a technology that allows for the identification and quantification of metabolites produced by the biological systems and, through the analysis of post genomics, can express individuals biochemical phenotype, which is groundbreaking in the way that the approach for health grievances is done. The study of genomics (genes), transcriptomics (mRNA), proteomics (proteins) and metabolomics composes a new technology known as OMICS. Metabolomics differs from the others for it globally evaluates a systems metabolites (cell, tissue or organism). In this way, it may not only be used for the comprehension of normal physiology,...

Medicina personalizada,metabolômica,metabolomics,medicina diagnóstica,diagnosis,metabolismo,agricultura de precisão,pecuária de precisão,ômicas,and biológicos

Ionmedicine operates in the Biotechnology research industry.

Ionmedicine's revenue is 11m - 100m

Ionmedicine has 11 - 50 employees.